BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8418023)

  • 1. Angiotensin II, sodium, and cardiovascular hypertrophy in spontaneously hypertensive rats.
    Harrap SB; Mitchell GA; Casley DJ; Mirakian C; Doyle AE
    Hypertension; 1993 Jan; 21(1):50-5. PubMed ID: 8418023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between cardiovascular hypertrophy and cardiac baroreflex function in spontaneously hypertensive and stroke-prone rats.
    Minami N; Head GA
    J Hypertens; 1993 May; 11(5):523-33. PubMed ID: 8390524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term.
    Harrap SB; Van der Merwe WM; Griffin SA; Macpherson F; Lever AF
    Hypertension; 1990 Dec; 16(6):603-14. PubMed ID: 2246027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II induces cardiovascular hypertrophy in perindopril-treated rats.
    Black MJ; Bertram JF; Campbell JH; Campbell GR
    J Hypertens; 1995 Jun; 13(6):683-92. PubMed ID: 7594427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats.
    Campbell DJ; Duncan AM; Kladis A; Harrap SB
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):426-36. PubMed ID: 8583785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-over study comparing effects of treatment with an angiotensin converting enzyme inhibitor and an angiotensin II type 1 receptor antagonist on cardiovascular changes in hypertension.
    Gillies LK; Werstiuk ES; Lee RM
    J Hypertens; 1998 Apr; 16(4):477-86. PubMed ID: 9797193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
    O'Sullivan JB; Black MJ; Bertram JF; Bobik A
    J Hypertens; 1994 Oct; 12(10):1163-70. PubMed ID: 7836732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats.
    Black MJ; Kanellakis P; Bobik A
    J Hypertens; 1997 Sep; 15(9):945-54. PubMed ID: 9321741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANP and bradycardic reflexes in hypertensive rats: influence of cardiac hypertrophy.
    Thomas CJ; Head GA; Woods RL
    Hypertension; 1998 Sep; 32(3):548-55. PubMed ID: 9740624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular status following combined angiotensin-converting enzyme and AT1 receptor inhibition in conscious spontaneously hypertensive rats.
    Duke LM; Paull JR; Widdop RE
    Clin Exp Pharmacol Physiol; 2003; 30(5-6):317-23. PubMed ID: 12859420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent effects on blood pressure and renal haemodynamics following chronic angiotensin converting enzyme inhibition with perindopril.
    Harrap SB; Nicolaci JA; Doyle AE
    Clin Exp Pharmacol Physiol; 1986; 13(11-12):753-65. PubMed ID: 3030586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of perindopril on cardiovascular hypertrophy of the SHR: respective roles of reduced blood pressure and reduced angiotensin II levels.
    Black MJ; Campbell JH; Campbell GR
    Am J Cardiol; 1993 Jun; 71(17):17E-21E. PubMed ID: 8328362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension.
    Dominiczak AF; Devlin AM; Lee WK; Anderson NH; Bohr DF; Reid JL
    Hypertension; 1996 Mar; 27(3 Pt 2):752-9. PubMed ID: 8613236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling of angiotensin II-angiotensin-(1-7) counterbalance in disease progression in spontaneously hypertensive rats treated with/without perindopril.
    Zhou X; Shang D; Zhang T; Li L; Zhou T; Lu W
    Pharmacol Res; 2012 Aug; 66(2):177-84. PubMed ID: 22513176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of cardiac, but not vascular, hypertrophy in the cardiac baroreflex deficit in spontaneously hypertensive and stroke-prone rats.
    Head GA; Minami N
    Am J Med; 1992 Apr; 92(4B):54S-59S. PubMed ID: 1533747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of perindopril on vascular smooth muscle polyploidy in stroke-prone spontaneously hypertensive rats.
    Devlin AM; Gordon JF; Davidson AO; Clark JS; Hamilton CA; Morton JJ; Campbell AM; Reid JL; Dominiczak AF
    J Hypertens; 1995 Feb; 13(2):211-8. PubMed ID: 7615951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent effects of perindopril on blood pressure and small-artery structure.
    Thybo NK; Korsgaard N; Eriksen S; Christensen KL; Mulvany MJ
    Hypertension; 1994 May; 23(5):659-66. PubMed ID: 8175177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perindopril treatment affects both preglomerular renal vascular lumen dimensions and in vivo responsiveness to vasoconstrictors in spontaneously hypertensive rats.
    Bergström G; Johansson I; Stevenson KM; Kett MM; Anderson WP
    Hypertension; 1998 Apr; 31(4):1007-13. PubMed ID: 9535428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pivotal role of the renin-angiotensin system in Lyon hypertensive rats.
    Lantelme P; Lo M; Luttenauer L; Sassard J
    Am J Physiol; 1997 Nov; 273(5):R1793-9. PubMed ID: 9374825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of angiotensin-(1-7) in conscious spontaneously hypertensive rats.
    Widdop RE; Sampey DB; Jarrott B
    Hypertension; 1999 Oct; 34(4 Pt 2):964-8. PubMed ID: 10523392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.